Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Prep: Cook: Serves:

The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.

UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.

Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Can Covid-19 increase the risk of developing Parkinson’s?

Last Month

Next Month

Go Back

Share this story

Comments

Women and Parkinson's

“We need to be having more conversations about menopause”

One woman’s story about the approach of menopause

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Cambridge Uni to build ‘state-of-the-art’ Parkinson's research facility

Leading MEP declares Parkinson’s “a European priority issue”

Campaigners advocate for better EU policy towards Parkinson’s

New evidence fruit compound could support Parkinson’s disease treatment

A new study from researchers in the US and South Korea suggests farnesol, a natural compound found in fruit, may be beneficial in treating Parkinson’s disease. The team used mice models to test the compound’s role in deactivating PARIS – a protein which can contribute to Parkinson’s onset by reducing the shields around dopamine-producing neurons. For one week, they fed mice a diet containing farnesol and compared them with mice who were fed a normal diet. They then administered the mice with alpha-synuclein protein linked to Parkinson’s effects in the brain. The findings revealed that the mice that had consumed farnesol had twice the number of healthy dopamine neurons as the control group, and performed better in tests designed to assess Parkinson’s symptoms. The researchers concluded that, while safe doses for humans have not yet been determined, “farnesol may be beneficial in the treatment of Parkinson’s disease”.

Turmeric oil may offer new ways of treating Parkinson’s disease

Turmeric oil may be beneficial in treating Parkinson’s disease, according to researchers from Kumamoto University in Japan. Their findings support the known properties of aromatic turmerone (ar-turmerone), a compound found in turmeric essential oil, which reduces inflammatory responses caused by cells associated with Parkinson’s-related neurodegeneration. Using midbrain slice cultures – laboratory cellular models that mimic brain activity – the team analysed the effects of a natural form of aromatic turmerone and eight structurally similar derivatives. They tested the derivatives’ anti-inflammatory effects, as well as their ability to protect dopamine-producing neurons. Those with the strongest anti-inflammatory effects were found to prevent the loss of dopamine-producing neurons. Among these were aromatic turmerone and its derivatives, suggesting their role as a “potential candidate for treating Parkinson’s disease”. In a press release, lead author Takahiro Seki said: “Our study elucidated a new mechanism by which ar-turmerone and its derivatives directly protect … [dopamine-producing] neurons.”

Research offers new insights on a cause of Parkinson’s disease

Researchers in Denmark have shared insights on a cause of up to 95% of Parkinson’s disease cases. Using data on gene patterns and three mouse models, scientists at the University of Copenhagen found that a blockage to a pathway regulating mitochondria (‘powerhouses’ that generate energy for reactions in cells) causes a form of the condition known as ‘sporadic Parkinson’s disease’. When the pathway becomes blocked by a protein, damaged mitochondria accumulate, unable to produce enough energy – which in turn causes nerve cells to die. “Just like when people eat, cells take what they need and get rid of … waste products,” explained corresponding study author Professor Shohreh Issazadeh-Navikas. “But if our brain cells have this specific kind of signalling blockage, it means that the powerhouse of the cell – mitochondria – cannot get cleaned up after being damaged.” The team now plan to investigate the pathway’s role in neuronal…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Women and Parkinson's

“We need to be having more conversations about menopause”

Advances

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Europe

Leading MEP declares Parkinson’s “a European priority issue”

New evidence fruit compound could support Parkinson’s disease treatment

Turmeric oil may offer new ways of treating Parkinson’s disease

Research offers new insights on a cause of Parkinson’s disease

{title}

Subscribe

Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Women and Parkinson's

“We need to be having more conversations about menopause”

Advances

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Europe

Leading MEP declares Parkinson’s “a European priority issue”

New evidence fruit compound could support Parkinson’s disease treatment

Turmeric oil may offer new ways of treating Parkinson’s disease

Research offers new insights on a cause of Parkinson’s disease

{title}

Subscribe

Sign in